Tower Research Capital LLC (Trc) Cybin Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.26 - $0.47 $1,692 - $3,060	-6,511 Reduced 19.36%	27,118 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.54 - $1.11 $9,895 - $20,340	18,325 Added 119.74%	33,629 $16,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.88 $4,189 - $8,992	10,219 Added 200.96%	15,304 $9,000
Q1 2022 May 12, 2022	BUY	$0.74 - $1.22 $3,762 - $6,203	5,085 New	5,085 $4,000
Q4 2021 Feb 14, 2022	SELL	$1.13 - $2.31 $552 - $1,129	-489 Closed	0 $0

Q3 2021 Nov 15, 2021	BUY	$1.83 - $3.18 $894 - $1,555	489 New	489 $1,000

109

243M

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.